Sermorelin Lab Monitoring: What Providers May Check Before and During Treatment

If you’re considering sermorelin, you may be wondering what “getting your labs done” actually involves. And sermorelin lab monitoring can sound clinical or intimidating at first. But it’s an important part of provider-guided care, helping your provider monitor your response and make informed treatment decisions throughout your therapy. 

Specific labs may be ordered at baseline (before you begin) and at intervals during treatment. However, the exact tests a provider orders will vary based on your individual health history and their clinical judgment. This article covers the types of labs a provider may consider, why each one may be important, and what happens with the results.

‍

Why Lab Monitoring Matters in Sermorelin Therapy

Instead of directly delivering growth hormone (GH), sermorelin stimulates the pituitary gland to release GH. You can read more about how sermorelin works for a more in-depth overview, but the short version is that your body’s natural feedback systems remain active.

With that said, your provider still needs objective data to confirm whether your treatment is working appropriately and whether your IGF-1 levels are moving into an appropriate range. Without baseline labs, there’s no reference point to measure progress against, and no way to catch a pre-existing condition that might affect how you respond.

On top of the above, growth hormone secretion naturally declines by roughly 14-15% per decade after age 30, which may be part of why some adults report slower recovery, lower energy, and reduced muscle tone as the years go by. And knowing your specific starting point through lab work gives your provider a specific baseline to work from. 

If you're weighing your options, it may also help to understand how sermorelin differs from synthetic HGH.

‍

Labs a Provider May Consider Before Starting Sermorelin

Before prescribing sermorelin, a provider will typically want to establish a baseline picture of your hormonal and metabolic health. This is standard clinical practice for any prescription peptide therapy. Put simply, a sermorelin blood test panel gives your provider a starting map.

Keep in mind that not every provider will order every test listed below. The specific panel depends on your individual health history, symptoms, and clinical judgment.

‍

IGF-1 (Insulin-Like Growth Factor-1)

IGF-1 is the primary biomarker used to assess growth hormone activity. So, why is it useful when taking sermorelin?

Growth hormone is released in short pulses and fluctuates throughout the day, meaning a single blood draw doesn’t tell you much. IGF-1, on the other hand, is produced by your liver in response to growth hormone stimulation and stays relatively stable in the bloodstream. And this stability makes it a far more practical and reliable marker for measuring and determining sermorelin’s effects.

In many ways, you can think of IGF-1 monitoring as a downstream signal that reflects how much growth hormone your body has been producing over time.

Additionally, a baseline IGF-1 level helps your provider understand where you’re starting and what a target range for you might look like. Because IGF-1 naturally declines with age, your provider will interpret your results in the context of your age, sex, and symptoms rather than a one-size-fits-all number. Reference ranges vary by lab and age group, which is exactly why professional interpretation is important. (If you want more of an explanation, learn more about IGF-1 and growth hormone in this article.)

‍

Growth Hormone (GH) Levels

Some providers might also check baseline growth hormone (GH) levels, though GH is used less often. 

Since it’s released in bursts, a single blood draw may not reflect your true average output. In fact, GH testing tends to be more relevant in clinical settings where a formal growth hormone deficiency is being evaluated. For most ongoing monitoring, IGF-1 is the main marker, with GH testing adding helpful context in certain cases.

‍

Thyroid Function (TSH, Free T3, Free T4)

An underactive thyroid (hypothyroidism) can blunt your body’s response to growth hormone stimulation, which means it may interfere with how sermorelin works. 

Your thyroid regulates metabolism and energy production, and if it’s underperforming, sermorelin may not produce the expected response. This is because your pituitary needs adequate thyroid hormone to respond to sermorelin’s signal; when thyroid levels are low, the same dose can trigger a weaker growth hormone release. 

Thus, identifying and addressing a thyroid issue first helps clear the way for effective treatment, which is why a provider may want to check it before or alongside starting therapy. TSH (thyroid-stimulating hormone) is the most common initial screen, with Free T3 and Free T4 offering more detail if TSH comes back abnormal. 

‍

Metabolic Panel (Blood Glucose, Insulin, HbA1c)

Elevated GH or IGF-1 levels may affect how your body processes glucose. In turn, your provider may want a baseline picture of your metabolic health. This panel may include a fasting glucose, HbA1c (a roughly three-month average of your blood sugar), or fasting insulin. 

‍

Comprehensive Metabolic Panel (CMP) and Liver Function

A CMP may be ordered to assess kidney and liver function, electrolytes, and overall metabolic health. Since IGF-1 is produced in the liver, liver health can offer some relevant context, and a CMP gives your provider a fuller picture of how your body is functioning before treatment begins.

‍

Lipid Panel

GH also plays a role in lipid metabolism, meaning some providers may include a baseline cholesterol and triglyceride panel. In fact, GH activity may be associated with changes in lipid profiles, and having a baseline allows your provider to track any changes over time.

‍

Complete Blood Count (CBC)

A CBC measures your red blood cells, white blood cells, and platelets, and it’s a common baseline health screen. It can help identify underlying conditions, such as anemia, that could affect your energy levels and make it harder to interpret your response to treatment.

‍

Labs a Provider May Monitor During Sermorelin Treatment

While labs are important as a baseline, lab monitoring is also part of an ongoing process throughout sermorelin treatment. For instance, follow-up peptide therapy labs and other ongoing testing procedures allow your provider to assess your response, adjust your dose, and confirm that IGF-1 levels are moving toward an appropriate range without exceeding it.

At the same time, follow-up intervals vary by provider and by how you respond. But IGF-1 is typically the primary marker rechecked at intervals, commonly around three to six months after starting treatment. This is what provider-guided dosing actually looks like in practice; your provider combines objective lab data with how you’re feeling to make informed adjustments, instead of setting a dose once and never revisiting it.

With Eden’s model, 24/7 provider messaging also means you can flag symptoms or questions between scheduled check-ins, adding an extra layer of safety and responsiveness to the process.

‍

What Happens If a Lab Result Is Outside the Expected Range?

A lab value outside the reference range doesn’t automatically mean treatment stops. It means your provider now has useful information to act on.

For example, if your IGF-1 rises above the appropriate range, they may reduce your dose. If thyroid function is low, they may recommend addressing that before or alongside sermorelin. If blood glucose shows early signs of insulin resistance, they may monitor more closely or adjust your plan. 

Lab monitoring exists precisely so these signals can be caught and addressed early—before they become more significant concerns. It also pairs naturally with paying attention to how you feel day to day; if you experience any of the common sermorelin side effects, it’s important to discuss it with your provider to determine what the next best step is for you.

‍

How Eden Supports Ongoing Lab Monitoring and Provider Oversight

Baseline testing, follow-up checks, and dose adjustments are part of Eden’s sermorelin injection program, with your licensed provider determining the appropriate monitoring plan based on your individual needs. It all begins with a quick online intake. From there, Eden connects you with a licensed provider who reviews your health history and goals, determining what’s appropriate for you and your situation. Dose adjustments and follow-up check-ins are designed into the program, supporting responsible GH support labs and ongoing monitoring.